Skip to search formSkip to main contentSkip to account menu

antiestrogen therapy

Known as: therapy, antiestrogen 
Drug treatment to block the action of the female hormone estrogen.
National Institutes of Health

Related topics

Related topics

1 relation
Hormone Therapy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life.
PURPOSE This study examines the impact of yoga, including physical poses, breathing, and meditation exercises, on quality of life… 
Highly Cited
2006
Highly Cited
2006
A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling.
The status of the 66-kDa human estrogen receptor-alpha (hER-alpha66) is a critical determinant in the assessment of the prognosis… 
Review
2003
Review
2003
Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
Antiestrogens include agents such as tamoxifen, toremifene, raloxifene, and fulvestrant. Currently, tamoxifen is the only drug… 
Review
2003
Review
2003
Understanding and managing cancer cachexia.
Highly Cited
1995
Highly Cited
1995
SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens
Review
1994
Review
1994
Sex hormone receptors in non-small-cell lung cancer in human beings.
Highly Cited
1991
Highly Cited
1991
Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen…
Tamoxifen (TXF), a triphenylethylene antiestrogen, is the major therapeutic agent for breast cancer. In rare cases, TXF treatment… 
Highly Cited
1991
Highly Cited
1991
Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer…
The most potent steroid in human prostatic carcinoma LNCaP cells, i.e., dihydrotestosterone (DHT), has a biphasic stimulatory… 
Review
1990
Review
1990
Endocrine pharmacology of antiestrogens as antitumor agents.
I. Introduction IN 1958, Lerner and co-workers (1) described the biological properties of the first nonsteroidal antiestrogen… 
Highly Cited
1986
Highly Cited
1986
Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa).
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)